Pilulka Lékárny a.s. Cash Flow Statement

Financials in millions CZK. Fiscal year is January - December.

Millions CZK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-38.51	-126.38	-175.87	-64.01	-24.68
Depreciation & Amortization	36.58	66.59	76.4	102.2	34.89
Other Adjustments	10.45	22.1	11.44	0.67	8.87
Change in Receivables	17.97	93.26	23.94	-20.96	-28.25
Changes in Inventories	-7.77	39.7	91.04	25.08	-64.63
Changes in Accounts Payable	-22.17	-127.93	-50.8	-14.09	99.03
Changes in Other Operating Activities	-16.97	-12.33	-10.43	-4.56	-0.06
Operating Cash Flow	-20.43	-44.99	-34.29	-38.15	24.67
Operating Cash Flow Growth	-	-	-	-	233.83%
Capital Expenditures	1.08	-20.06	-35.63	-76.77	-82.13
Sale of Property, Plant & Equipment	1.72	8.56	0.02	0.1	0.05
Investing Cash Flow	2.8	-11.5	-35.61	-76.68	-82.08
Long-Term Debt Issued	16.04	64.15	-1.1	4.66	-3.26
Net Long-Term Debt Issued (Repaid)	16.04	64.15	-1.1	4.66	-3.26
Issuance of Common Stock	-	-	67.39	0.02	0
Net Common Stock Issued (Repurchased)	-	-	67.39	0.02	0
Financing Cash Flow	16.04	64.15	66.29	4.68	-3.26
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-1	-1.08	0.45	0.45	-
Net Cash Flow	-2.58	6.58	-3.17	-109.69	-60.17
Free Cash Flow	-19.35	-65.05	-69.92	-114.92	-57.46
FCF Margin	-2.21%	-4.99%	-3.28%	-4.70%	-2.41%
Free Cash Flow Per Share	-7.15	-24.03	-25.83	-45.58	-22.98
Levered Free Cash Flow	-32.09	-115.62	-105.47	-28.41	-41.67
Unlevered Free Cash Flow	-24.06	-155.4	-77.98	-17.1	-27.46